Suchergebnisse - "Brown, Jennifer R"

PubPharm (447)

1

Clinical Risks for Chronic Lymphocytic Leukemia

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2024

von Brown, J.

2

Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib

enthalten in: Blood advances | 2024

von Moslehi, J. | Furman, R. | Tam, C. | +8

3

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

enthalten in: Molecular cancer therapeutics | 2024

von Arribas, A. | Napoli, S. | Cascione, L. | +21

UpdateOf: bioRxiv. 2023 Jan 02;:. - PMID 36711490

4

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies : post-hoc analysis of a large clinical trial safety database

enthalten in: Haematologica | 2024

von Brown, J. | Ghia, P. | Jurczak, W. | +14

5

Venetoclax Initiation in Chronic Lymphocytic Leukemia : International Insights and Innovative Approaches for Optimal Patient Care

enthalten in: Cancers | 2024

von Anderson, M. | Walewska, R. | Hackett, F. | +8

6

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

enthalten in: Blood advances | 2024

von Ahn, I. | Brander, D. | Ren, Y. | +20

7

Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology : A Goldilocks Approach to Bone Marrow Testing

enthalten in: JCO oncology practice | 2024

von AlJabban, A. | Paik, H. | Aster, J. | +29

8

Long-term Follow-up from A041202 Shows Continued Efficacy of Ibrutinib Regimens for Older Adults with CLL

enthalten in: Blood | 2024

von Woyach, J. | Perez Burbano, G. | Ruppert, A. | +29

9

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

enthalten in: Annals of hematology | 2024

von Merryman, R. | Redd, R. | Freedman, A. | +22

10

Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition

enthalten in: Leukemia & lymphoma | 2023

von Leung, B. | Fay, C. | Said, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]